A third of Covid-19 survivors suffer 'brain disease

Long-term effects of Covid-19 infection

As many as one in three people infected with Covid-19 have longer-term mental health or neurological symptoms, researchers reported Tuesday.

They found 34% of Covid-19 survivors received a diagnosis for a neurological or psychological condition within six months of their infection, according to the study published Tuesday in the journal Lancet Psychiatry. The most common diagnosis was anxiety, found in 17% of those treated for Covid-19, followed by mood disorders, found in 14% of patients.

And while the neurological effects are more severe in hospitalized patients, they are still common in those who were only treated in an outpatient setting, the researchers note.

"That rate increased progressively as the severity of the Covid-19 illness increased. If we look at patients who were hospitalized that rate increased to 39%," said Maxime Taquet, an academic clinical fellow in psychiatry at the University of Oxford, and a co-author of the new study.

The results help light the way for how the healthcare system ought to continue helping Covid-19 survivors, the researchers said.
"Our results indicate that brain diseases and psychiatric disorders are more common after Covid-19 than after flu or other respiratory infections, even when patients are matched for other risk factors. We now need to see what happens beyond six months," Taquet added.

Covid-19 as a 'brain disease'
It's the largest study of its kind yet and involved the electronic health records of more than 236,000 Covid-19 patients, mostly in the US. The researchers compared their records with those who experienced other respiratory tract infections during the same time frame.
They observed that those with Covid-19 had a 44% increased risk for neurological and psychiatric illness compared to people recovering from flu. And they were 16% more likely to experience those effects compared with people with other respiratory tract infections.

However, Covid-19 didn't necessarily increase the risk for the full spectrum of neurological illness.
"Two important negative findings were related to parkinsonism and Guillain-Barré syndrome," Taquet said. "Both of those conditions are neurological conditions that we know are sometimes associated with the viral infection. We did not find that they were more common after Covid-19 and after the other respiratory tract infections that we looked at."

The study was important, in part, because of the sheer number of patient records the researchers were able to analyze, according to Dr Musa Sami, a clinical associate professor in psychiatry at the University of Nottingham.
"This is a robust piece of work in a large cohort demonstrating the association between Covid-19 and psychiatric and neurological complications," he said in a statement. "This is a very important topic as there has been considerable consternation regarding Covid-19 as a 'brain disease.'"

Sami, who was not associated with the study, highlighted the need for further investigation into how, exactly, Covid-19 affects the brain and nervous system. "Psychological stress, longer stays in hospital, and characteristics of the illness itself may play a part," he said.
One clue: psychological symptoms are more common than severe neurological complications, according to Masud Husain, a professor of neurology and cognitive science at the University of Oxford, and a co-author of the study.
"It's really the people with very severe illness who are at higher risk of developing the neurological complications, unlike what we see with the mental health complications, which is much more across the board with severity," he said.

Other, smaller studies have pointed to the result. One study in February followed 381 patients treated for Covid-19 at a hospital in Rome, Italy and found that 30% of them experienced post-traumatic stress disorder after recovery.

A December study in the journal Neurology: Clinical Practice showed that Covid-19 could cause seizures and movement disorders, even in some moderate cases.

https://edition.cnn.com/2021/04/06/health/covid-neurological-psychological-lancet-wellness/index.html 

Tags : #Covid19Aftereffects #Brainfog #LancetPsychiatry #DrMusaSami #Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024